Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Kidney therapy in burn victims: does it help or just extend hospital stays?

NCT ID NCT07195565

Knowledge-focused Sponsor: Pinar Timur Tasci Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked back at the medical records of 238 severely burned adults who needed continuous kidney therapy (CRRT) in the intensive care unit. The goal was to see how the timing of starting CRRT and the severity of kidney injury related to survival and how long patients stayed in the hospital. The findings help doctors understand which patients might benefit most from this treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

238 people

The number who actually took part.

Started

Jan 2021

Finished

Jan 2024

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult patients (≥18 years) admitted to and treated in the Burn Intensive Care Unit.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged 18 years and older * Admitted to and treated in the Burn Intensive Care Unit Exclusion Criteria: * Patients with an ICU stay of less than 24 hours * Patients younger than 18 years * Patients with known chronic kidney disease or history of kidney transplantation * Patients admitted with toxic epidermal necrolysis (TEN) * Patients with estimated glomerular filtration rate (eGFR) ≤ 15 mL/min/1.73m² at admission

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute kidney injury are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

acute kidney injury burn Critical Illness

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Acute kidney injury Critical illness Severe burns

Contacts and locations

Locations

  • Dr. Lutfi Kirdar City Hospital, Department of Anesthesiology and Reanimation

    Istanbul, 34865, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.